Oct 13, 2020 / 07:00PM GMT
Philip Toleikis - Sernova Corp. - President, CEO
Hello, everyone. Welcome to the Sernova Corp presentation. My name is Dr. Philip Toleikis, President and CEO of Sernova Corp. And I just want to show my appreciation for being invited to the Cell & Gene Meeting on the Mesa in 2020. Today, I'm going to go over Sernova Corp, and in terms of our regenerative medicine approach, and update everyone on our clinical trials as we're looking forward.
So Sernova itself is an innovator and a leader in this field. We've been working on the cell therapy approach for therapeutics for over 11 years and we are now in clinical trials, and I'm going to show you some of the successes that we've had with our therapeutic cell and device approach. We are working both on diabetes program, and we also have the hemophilia A, and thyroid preclinical programs for which well we have validated our technology in.
Sernova's approach takes three types of applications here. So first, we've developed what we call a cell pouch, and the cell pouch technology is highly scalable. And this is an implantable device. It is
Sernova Corp at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) Transcript
Oct 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers